Premium
Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia
Author(s) -
ANDERSSON J KERSTIN,
RYBO GÖRAN
Publication year - 1990
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1990.tb16240.x
Subject(s) - levonorgestrel , medicine , intrauterine device , blood loss , hysterectomy , menstruation , obstetrics , gynecology , surgery , population , family planning , research methodology , environmental health
Summary. In 20 women with menorrhagia (>80 ml blood loss per menstrual period) a levonorgestrel‐releasing intrauterine device (Lng‐IUCD) was inserted. Menstrual blood loss (MBL) was measured in two consecutive cycles before the device was inserted and after 3, 6 and 12 months of use. MBL was significantly reduced after 3 months (86%) and after 12 months the reduction was 97%. There was a significant increase ( P < 0.001) in serum ferritin during the first year of Lng‐IUCD use. The Lng‐IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia.